Peter Scott Chin insider trades

Open-market stock purchases and sales by Peter Scott Chin, Chief Medical Officer at Denali Therapeutics Inc, from SEC Form 4 filings since Sep 4, 2026.

Recent trades

DateStockTradeValue
Sep 4, 2026DNLI Denali Therapeutics IncSold$36.9K

Companies traded

  • DNLI Denali Therapeutics Inc: 1 sale, last Sep 4, 2026

Get free alerts when Peter Scott Chin files a new trade →